An international meeting aims to shake up donor−recipient relations in a quest for more enduring health gains, reports Beverly Petersen Stearns.

India has a heavy TB burden but has the technological capacity to deal with it. T.V. Padma reports.

More than 6,000 US clinical trials are now conducted overseas, and the number is quietly rising in South America.

Researchers are stepping up efforts to finding new treatments for Chagas disease, with three drug candidates in clinical trials.

The recent nuclear scare in Japan has reinforced pressure in China to raise its awareness of the risks of new technologies. Li Jiao reports.

The pursuit of an AIDS vaccine has boosted African research and capacity to conduct trials, and encouraged other countries to follow suit.

New vaccines normally take years to reach developing countries, but the WHO hopes it can shorten the time drastically for dengue vaccine.

Mosquitoes are growing resistant to pyrethroids, the only WHO-approved insecticides used in bednets.

GAVI's model of giving "more and more money" is unsustainable and unaffordable, say critics.

Priya Shetty explores the tools and partnerships that help the public health community counter the threat of counterfeit medicines.

The fight against counterfeits is deploying scanners, spectrometers and minilabs, but nothing can replace national regulatory systems, says Yojana Sharma.

New TB vaccines are facing a major funding shortfall, says Mićo Tatalović, and some countries seem resistant to accepting a future vaccine.

Scientists say that Bangladesh's Nipah virus could be stopped by protecting the date palm sap that its fruit bat carriers enjoy.

A dispute over the HINARI scheme, which gives poor countries free journal access, has exposed the sensitive border between aid and commerce, finds Yojana Sharma.

Thirty years since the eradication of smallpox, we are yet to beat polio and malaria, and scientists are discussing new courses of action.

The Grand Challenges initiative has highlighted science's role in saving lives, but it will take longer to achieve concrete results, Bill Gates admits.

Can developing countries use nanotechnology to improve health? Priya Shetty looks at nanomedicine's promise.

South Africa is using nanotechnology to improve existing tuberculosis drugs. Munyaradzi Makoni looks at a developing country's experience.

A microbicide gel showed promise for the first time this year, but a range of HIV prevention could hit shelves in the next few years.

A range of crops rich in micronutrients will be launched from next year, but is the developing world ready, asks Tatum Anderson?